{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19(1)"],"submitter":["Lai M"],"pubmed_abstract":["<h4>Introduction</h4>Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.<h4>Case presentation</h4>We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months.<h4>Conclusion</h4>DILI secondary to liraglutide appears to be a rare but an important adverse effect."],"journal":["Case reports in gastroenterology"],"pagination":["653-658"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12503594"],"repository":["biostudies-literature"],"pubmed_title":["Liraglutide-Induced Liver Injury: A Case Report and Review."],"pmcid":["PMC12503594"],"pubmed_authors":["Nicoll A","Hosking P","Sawhney R","Lai M"],"additional_accession":[]},"is_claimable":false,"name":"Liraglutide-Induced Liver Injury: A Case Report and Review.","description":"<h4>Introduction</h4>Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.<h4>Case presentation</h4>We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months.<h4>Conclusion</h4>DILI secondary to liraglutide appears to be a rare but an important adverse effect.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan-Dec","modification":"2026-06-04T07:40:01.988Z","creation":"2026-06-01T03:06:14.576Z"},"accession":"S-EPMC12503594","cross_references":{"pubmed":["41064547"],"doi":["10.1159/000547634"]}}